Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxim Sorokin

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Biomedicines|July 27, 2022
Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients' Survival: A Pilot StudyOlga V Kovaleva, Polina Podlesnaya, Maxim Sorokin, et al.
Frontiers in Oncology|October 15, 2021
RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual BiosamplesMaxim Sorokin, Alexander Gorelyshev, Victor Efimov, et al.
Seminars in Cancer Biology|June 24, 2018
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugsAnton Buzdin, Maxim Sorokin, Andrew Garazha, et al.
Aging|November 22, 2016
Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cellsIvan Petrov, Maria Suntsova, Olga Mutorova, et al.
Cancers|July 24, 2021
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of <i>CRNDE</i> as a Poor Survival Prognosis Biomarker in GlioblastomaMaxim Sorokin, Mikhail Raevskiy, Alja Zottel, et al.
Cell Death and Differentiation|May 23, 2018
Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosisJoseph Sarhan, Beiyun C Liu, Hayley I Muendlein, et al.
Frontiers in Molecular Biosciences|February 5, 2025
Detection of fusion events by RNA sequencing in FFPE versus freshly frozen colorectal cancer tissue samplesMaxim Sorokin, Vladimir Lyadov, Maria Suntsova, et al.
BMC Cancer|November 1, 2022
Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing dataMaxim Sorokin, Marianna Zolotovskaia, Daniil Nikitin, et al.
Scientific Data|April 25, 2019
Atlas of RNA sequencing profiles for normal human tissuesMaria Suntsova, Nurshat Gaifullin, Daria Allina, et al.
Oncogene|September 24, 2021
Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypesTimofey Lebedev, Elmira Vagapova, Pavel Spirin, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Biomedicines|July 27, 2022
Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients' Survival: A Pilot StudyOlga V Kovaleva, Polina Podlesnaya, Maxim Sorokin, et al.
Frontiers in Oncology|October 15, 2021
RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual BiosamplesMaxim Sorokin, Alexander Gorelyshev, Victor Efimov, et al.
Seminars in Cancer Biology|June 24, 2018
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugsAnton Buzdin, Maxim Sorokin, Andrew Garazha, et al.
Aging|November 22, 2016
Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cellsIvan Petrov, Maria Suntsova, Olga Mutorova, et al.
Cancers|July 24, 2021
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of <i>CRNDE</i> as a Poor Survival Prognosis Biomarker in GlioblastomaMaxim Sorokin, Mikhail Raevskiy, Alja Zottel, et al.
Cell Death and Differentiation|May 23, 2018
Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosisJoseph Sarhan, Beiyun C Liu, Hayley I Muendlein, et al.
Frontiers in Molecular Biosciences|February 5, 2025
Detection of fusion events by RNA sequencing in FFPE versus freshly frozen colorectal cancer tissue samplesMaxim Sorokin, Vladimir Lyadov, Maria Suntsova, et al.
BMC Cancer|November 1, 2022
Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing dataMaxim Sorokin, Marianna Zolotovskaia, Daniil Nikitin, et al.
Scientific Data|April 25, 2019
Atlas of RNA sequencing profiles for normal human tissuesMaria Suntsova, Nurshat Gaifullin, Daria Allina, et al.
Oncogene|September 24, 2021
Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypesTimofey Lebedev, Elmira Vagapova, Pavel Spirin, et al.
Pageof 7